Dec 12, 2017 11:00 am UTC| Business
SAN FRANCISCO, Dec. 12, 2017 -- Malicious mobile apps are back on the rise, impersonating brands and fooling consumers, according to digital threat management leader RiskIQ in its Q3 mobile threat landscape report,...
Dec 12, 2017 11:00 am UTC| Business
ATLANTA, Dec. 12, 2017 -- KMS Technology, a provider of software development and testing services, announces the availability of Katalon Services, an offering to support the company’s popular Katalon Studio test...
Smyte Hires Seasoned SaaS & Security Software Exec to Lead Sales
Dec 12, 2017 11:00 am UTC| Business
SAN FRANCISCO, Dec. 12, 2017 -- Smyte has named Travis Reed as its Vice President of Sales, putting the company in a strong position to capitalize on a successful 2017, and to accelerate adoption of its SaaS...
Dec 12, 2017 11:00 am UTC| Business
SAN MATEO, Calif., Dec. 12, 2017 -- Cloudian, the innovation leader in enterprise object storage systems, today announced software that will connect Axis Communications’ network cameras to its Cloudian HyperStore object...
Dec 12, 2017 10:29 am UTC| Business
Authorization is also under the provision of the Conformity Assessment and Acceptance of Industrial Products (CAA) agreement between Israel and the European Union (EU), which will serve to qualify Pluristem’s facilities...
Genetic Technologies Provides Update on Strategic Review Initiative
Dec 12, 2017 10:00 am UTC| Business
MELBOURNE, Australia, Dec. 12, 2017 -- Genetic Technologies Limited (ASX:GTG) (NASDAQ:GENE) (“Company”), a molecular diagnostics company focused on cancer risk assessment, and provider of BREVAGenplus®, a...
Voip-Pal.com, Inc. Was Granted Notice of Allowance (Intention to Grant) of the RBR Patent in EUROPE
Dec 12, 2017 10:00 am UTC| Business
BELLEVUE, Wash., Dec. 12, 2017 -- Voip-Pal.com Inc. (“Voip-Pal”, “Company”) (OTCQB:VPLM) is pleased to announce it was granted Notice of Allowance (Intention to Grant) of its main parent patent, Routing, Billing Rating...
FDA Approval of Opdivo Injection Sparks Hope for Cancer Patients with Revolutionary Treatment Update